Newsfeeds - Spark Newswire

1 minute read

Johnson & Johnson-Backed Antiviral Candidate Effectively Prevents Influenza Infection

Today, 3:58 AM

Cidara Therapeutics Inc (NASDAQ: CDTX) announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388 against the H3N2 influenza A virus strain.

CDTX

1 minute read

Guggenheim Initiates Coverage On Johnson & Johnson with Neutral Rating, Announces Price Target of $161

By Benzinga Newsdesk

Today, 3:58 AM

Guggenheim analyst Vamil Divan initiates coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating and announces Price Target of $161.

JNJ

9 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 3:58 AM

On Friday, 135 companies reached new 52-week lows.

AFMD

2 minute read

Zhongchao Inc. Renews Partnership With Johnson & Johnson China

By Happy Mohamed

Today, 3:58 AM

Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the

JNJ

1 minute read

US Supreme Court Refuses To Reject $302M Judgment Against Johnson & Johnson Over Pelvic Mesh Marketing

By Vandana Singh

Today, 3:58 AM

The U.S. Supreme Court refused to hear Johnson & Johnson's (NYSE: JNJ) regarding a $302 million judgment in a lawsuit brought by California, accusing the company of concealing the risks of its pelvic mesh products.

JNJ

1 minute read

Johnson & Johnson Files For Debt Shelf Offering, Size Not Disclosed

By Michael Horton

Today, 3:58 AM

-SEC Filing

JNJ

1 minute read

Immunovant Could Potentially Be An M&A Target, Writes Analyst

By Vandana Singh

Today, 3:58 AM

Cantor Fitzgerald initiated coverage on Immunovant Inc (NASDAQ:IMVT) with an Overweight rating and a price target of $30. The company’s pipeline includes…

ARGX

1 minute read

JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals

By Vandana Singh

Today, 3:58 AM

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) received written notice from Janssen, a unit of Johnson & Johnson (NYSE:JNJ), to terminate their rights to JNJ-75220795, now called…

ARWR

1 minute read

US Judge Intends To Dismiss Johnson & Johnson’s Talc Subsidiary Bankruptcy

By Vandana Singh

Today, 3:58 AM

A three-judge panel of the Philadelphia-based 3rd U.S. Circuit Court of Appeals ruled to dismiss Johnson & Johnson's (NYSE: JNJ) subsidiary's bankruptcy case regarding talc-related claims.

JNJ

1 minute read

Johnson & Johnson’s Drug Acquired Via Momenta Deal Shows Encouraging Data In Fetal Disorder

By Vandana Singh

Today, 3:58 AM

Janssen, a unit of Johnson & Johnson (NYSE:JNJ), announced topline results from the proof-of-concept Phase 2 open-label UNITY trial for…

JNJ